Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tong

Showing results (171-180 of 253) with videos related to

Pageof 26
Sort By:
Scientific Reports|April 6, 2023
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birthBridget M Arman, Natalie K Binder, Natasha de Alwis, et al.
Plos One|September 8, 2020
Appropriate-for-gestational-age infants who exhibit reduced antenatal growth velocity display postnatal catch-up growthEmma J McLaughlin, Richard J Hiscock, Alice J Robinson, et al.
BMC Medicine|December 28, 2020
Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweightLucy M Kennedy, Stephen Tong, Alice J Robinson, et al.
Plos One|October 20, 2021
Accelerated fetal growth velocity across the third trimester is associated with increased shoulder dystocia risk among fetuses who are not large-for-gestational-age: A prospective observational cohort studyTeresa M MacDonald, Alice J Robinson, Richard J Hiscock, et al.
American Journal of Obstetrics and Gynecology|January 2, 2016
Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunctionFiona C Brownfoot, Roxanne Hastie, Natalie J Hannan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2010
Rational design of immunostimulatory siRNAsMichael P Gantier, Stephen Tong, Mark A Behlke, et al.
Journal of the American Heart Association|August 9, 2022
Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and PreeclampsiaRoxanne Hastie, Lina Bergman, Susan P Walker, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 19, 2023
Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restrictionShao Lim, Annie R A McDougall, Maya Goldstein, et al.
BMJ Open|December 30, 2022
Incidence and causes of stillbirth in the only tertiary referral hospital in the Solomon Islands: a hospital-based retrospective cohort studyManarangi Sajini De Silva, Leeanne Panisi, Lenin Manubuasa, et al.
Placenta|November 23, 2016
Steroid sulfatase is increased in the placentas and whole blood of women with early-onset preeclampsiaAmy M Gratton, Louie Ye, Fiona C Brownfoot, et al.
Pageof 26

Showing results (171-180 of 253) with videos related to

Sort By:
Pageof 26
Scientific Reports|April 6, 2023
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birthBridget M Arman, Natalie K Binder, Natasha de Alwis, et al.
Plos One|September 8, 2020
Appropriate-for-gestational-age infants who exhibit reduced antenatal growth velocity display postnatal catch-up growthEmma J McLaughlin, Richard J Hiscock, Alice J Robinson, et al.
BMC Medicine|December 28, 2020
Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweightLucy M Kennedy, Stephen Tong, Alice J Robinson, et al.
Plos One|October 20, 2021
Accelerated fetal growth velocity across the third trimester is associated with increased shoulder dystocia risk among fetuses who are not large-for-gestational-age: A prospective observational cohort studyTeresa M MacDonald, Alice J Robinson, Richard J Hiscock, et al.
American Journal of Obstetrics and Gynecology|January 2, 2016
Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunctionFiona C Brownfoot, Roxanne Hastie, Natalie J Hannan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2010
Rational design of immunostimulatory siRNAsMichael P Gantier, Stephen Tong, Mark A Behlke, et al.
Journal of the American Heart Association|August 9, 2022
Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and PreeclampsiaRoxanne Hastie, Lina Bergman, Susan P Walker, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 19, 2023
Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restrictionShao Lim, Annie R A McDougall, Maya Goldstein, et al.
BMJ Open|December 30, 2022
Incidence and causes of stillbirth in the only tertiary referral hospital in the Solomon Islands: a hospital-based retrospective cohort studyManarangi Sajini De Silva, Leeanne Panisi, Lenin Manubuasa, et al.
Placenta|November 23, 2016
Steroid sulfatase is increased in the placentas and whole blood of women with early-onset preeclampsiaAmy M Gratton, Louie Ye, Fiona C Brownfoot, et al.
Pageof 26